19-Dec-2025
Zynex Enters Chapter 11 and Faces Nasdaq Delisting
TipRanks (Thu, 18-Dec 5:13 PM ET)
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
TipRanks (Tue, 16-Dec 12:10 PM ET)
Zynex Files for Chapter 11 Bankruptcy
TipRanks (Tue, 16-Dec 8:28 AM ET)
Why Is Zynex Stock (ZYXI) Down Today?
TipRanks (Tue, 16-Dec 8:21 AM ET)
Zynex Financial Restructuring Puts Company on Path to Long-Term Success
PRNewswire (Tue, 16-Dec 8:00 AM ET)
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Benzinga (Tue, 16-Dec 5:53 AM ET)
Zynex Reports Third Quarter 2025 Financial Results
PRNewswire (Mon, 17-Nov 5:15 PM ET)
PRNewswire (Fri, 14-Nov 8:15 AM ET)
Zynex Sets Third Quarter 2025 Earnings Call
PRNewswire (Fri, 14-Nov 8:00 AM ET)
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
PRNewswire (Tue, 14-Oct 6:08 PM ET)
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Zynex trades on the NASDAQ stock market under the symbol ZYXI.
As of December 19, 2025, ZYXI stock price climbed to $0.29 with 9,059,268 million shares trading.
ZYXI has a beta of 3.25, meaning it tends to be more sensitive to market movements. ZYXI has a correlation of 0.10 to the broad based SPY ETF.
ZYXI has a market cap of $8.93 million. This is considered a Sub-Micro Cap stock.
Last quarter Zynex reported $13 million in Revenue and -$1.42 earnings per share. This fell short of revenue expectation by $-11 million and missed earnings estimates by -$1.26.
In the last 3 years, ZYXI traded as high as $17.25 and as low as $.23.
The top ETF exchange traded funds that ZYXI belongs to (by Net Assets): VTI, VXF, MSSM.
ZYXI has underperformed the market in the last year with a price return of -96.5% while the SPY ETF gained +18.1%. ZYXI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -81.0% and -67.0%, respectively, while the SPY returned +2.8% and -0.5%, respectively.
ZYXI support price is $.24 and resistance is $.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZYXI shares will trade within this expected range on the day.